Stinging Nettle

Stinging nettle is one of the few botanicals where the use-case map splits cleanly by plant part, and most product confusion on the US market comes from ignoring that split. Nettle ROOT is the BPH and lower-urinary-tract supplement. Nettle LEAF (or above-ground "aerial parts") is the allergic-rhinitis supplement. They are not interchangeable — different actives, different trials, different doses, different products. A label that just says "nettle" without naming the plant part is selling you ambiguity.

For BPH, four reasonably-designed trials underpin the modern evidence base. Safarinejad 2005 (PMID 16635963) randomized 620 men with BPH-related lower urinary tract symptoms to 6 months of nettle root extract vs placebo in a crossover trial — IPSS dropped significantly more in the nettle group, with improvements in peak urinary flow and post-void residual volume. Ghorbanibirgani 2013 (PMID 23487561) replicated the design in 100 Iranian men over 6 months and again found IPSS improvement vs placebo. Schneider 2004 (PMID 15045190) ran a 12-month placebo-controlled multicenter trial of the Bazoton-uno (IDS 23) standardized root extract in men with benign prostatic syndrome — improvement in IPSS confirmed. Lopatkin 2007 (PMID 18038253) is the long-term follow-up of the Sabal serrulata + Urtica dioica combination (the German "Prostagutt forte" preparation), 257 men over 96 weeks total — both the combination and the placebo-crossover arms maintained IPSS improvement. None of these trials showed dramatic prostate shrinkage; the signal is moderate-but-real symptom relief over months.

The mechanism is more honest than saw palmetto's. Nettle root contains lectins (UDA), phytosterols (beta-sitosterol, scopoletin), and polysaccharides. In vitro work (Gansser & Spiteller 1995, PMID 17238068) shows aromatase inhibition from root constituents, and nettle root binds sex hormone-binding globulin (SHBG) in a way that may modulate free testosterone and estradiol locally in prostate tissue. Whether any of this drives the IPSS effect in real men is unclear — but at least the in-vitro story lines up with the clinical signal in direction.

For allergic rhinitis, the headline trial is old but methodologically reasonable: Mittman 1990 (PMID 2192379) randomized 98 patients to 300mg twice daily of freeze-dried nettle leaf vs placebo for one week of acute hay-fever symptoms — 58% rated nettle moderate-to-effective vs 37% for placebo, a modest but real signal. Bakhshaee 2017 (PMID 29844782) tested nettle root extract (interestingly, not leaf) at 300mg/day for one month in 74 patients with allergic rhinitis and reported symptom improvement vs placebo. Roschek 2009 (PMID 19140159) showed in vitro that nettle extract antagonizes the histamine H1 receptor and inhibits tryptase release from mast cells — the proposed mechanism for allergy benefit. The allergy evidence is thinner than the BPH evidence: one positive RCT from 1990 and one positive smaller trial from 2017, both at modest effect sizes.

For osteoarthritis and "anti-inflammatory" claims, the evidence is much weaker. Randall 2000 (PMID 10911825) is a small RCT of topical nettle sting (yes, applying actual stinging leaves to the painful area) for base-of-thumb pain — interesting but not relevant to oral nettle supplements. There is no strong oral-supplement OA trial base. Anti-inflammatory claims based on in-vitro NF-kB or TNF-alpha inhibition do not translate to a meaningful human signal yet.

Practical bottom line: nettle root for BPH symptoms has the strongest evidence in the genus, comparable to or arguably stronger than saw palmetto's now-deflated body of work. Nettle leaf for allergic rhinitis has one decent old trial and one decent recent trial. Everything else — joint pain, hair, blood sugar, hypertension — is either preliminary or mechanism-talk. The stinging nettle + saw palmetto combination (Prostagutt forte) has the most rigorous long-term data of any single nettle preparation and is worth knowing about if you are stacking botanicals.